regulatory
confidence high
sentiment negative
materiality 0.55
BIO KEY INTERNATIONAL INC (BKYI): Nasdaq/NYSE listing notice — BIO-key receives Nasdaq extension to May 2026 to regain $1 bid price compliance
BIO KEY INTERNATIONAL INC
- Nasdaq granted BIO-key an additional 180-day period, until May 4, 2026, to meet the $1.00 minimum bid price rule.
- The extension follows a prior notice from May 9, 2025, and is contingent on meeting all other listing requirements.
- The company intends to effect a reverse stock split if necessary to cure the bid price deficiency.
- Failure to comply by May 4, 2026, will result in Nasdaq delisting; company may appeal.